Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Schizophrenia Research|August 8, 2022
Evaluation of major treatment failure in patients with recent-onset schizophrenia or schizophreniform disorder: A post hoc analysis from the Disease Recovery Evaluation and Modification (DREaM) studyLarry Alphs, Pamela Baker, Brianne Brown, et al.
Journal of Clinical Neurology (Seoul, Korea)|July 9, 2026
Efficacy and Safety of Nipocalimab in Adults With Generalised Myasthenia Gravis: An Asian Subgroup Analysis of the Vivacity-MG3 StudyYuriko Nagane, Huan Yang, Jin-Sung Park, et al.
Early Intervention in Psychiatry|March 5, 2010
Paliperidone extended-release tablets in patients with recently diagnosed schizophreniaCarla M Canuso, Cynthia A Bossie, Joan Amatniek, et al.
Schizophrenia Research|March 5, 2022
The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorderLarry Alphs, Brianne Brown, Ibrahim Turkoz, et al.
BMC Psychiatry|November 1, 2011
Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptomsWayne Macfadden, Caleb M Adler, Ibrahim Turkoz, et al.
The International Journal of Neuropsychopharmacology|December 16, 2022
Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRDDavid Williamson, Ibrahim Turkoz, Ewa Wajs, et al.
Schizophrenia Research|May 26, 2005
Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesiaGeorges M Gharabawi, Cynthia A Bossie, Robert A Lasser, et al.
JAMA Network Open|July 17, 2024
Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia: An Open-Label Extension Study of a Randomized Clinical TrialChristoph U Correll, Karen Johnston, Ibrahim Turkoz, et al.
Neuropsychiatric Disease and Treatment|November 28, 2024
Earlier Use of Long-Acting Injectable Paliperidone Palmitate Once-Monthly versus Oral Antipsychotics in Patients with Schizophrenia: An Integrated Patient-Level Meta Analysis of the PROSIPAL and PRIDE StudiesMartha Sajatovic, Monica Doring, Oliver J Lopena, et al.
Neuropsychiatric Disease and Treatment|December 9, 2021
Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled TrialsStephane Borentain, David Williamson, Ibrahim Turkoz, et al.
Pageof 10